The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VRDN FINANCIAL STATEMENTS

Viridian Therapeutics Inc — balance sheet, income statement and cash flow trends

VRDNViridian Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue71.1 M $Gross Profit70.8 M $ · 100%Operating Income-405.2 M $ · -570%Pre-tax Income-387 M $ · -544%Net Income to Owners-387 M $ · -544%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue71.1 M $+23,220.3%
Gross Profit70.8 M $+23,115.4%
Operating Income-405.2 M $—
EBITDA-368 M $—
Net Income to Owners-387 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.1 B
  • Equity662.1 M $60%
  • Current Liabilities63.8 M $6%
  • Long-term Liabilities371.3 M $34%

Key Figures

YoY change
Total Assets1.1 B $+88.4%
Total Liabilities435.1 M $+548.0%
Total Equity662.1 M $+28.5%
Cash & ST Investments981.5 M $+74.2%
Total Debt242.9 M $+1,038.1%
Net Debt77.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-500 M-250 M0-333.3 M $Operating-367.2 M $Investing748.2 M $Financing47.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-333.3 M $—
Capital Expenditures1.7 M $+217.0%
Free Cash Flow-335 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VRDN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.